Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART (Q61602587)
Jump to navigation
Jump to search
article
Language | Label | Description | Also known as |
---|---|---|---|
English | Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART |
article |
Statements
Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART. The Manif-2000 Study Group (English)
B Spire
D Vlahov
P Dellamonica
H Gallais
G Lepeu
Y Obadia